Oncora Medical
Oncora Medical (rebranded as Oncora AI in 2025) is a Philadelphia-based digital health company building oncology-specific AI software for cancer registry automation, clinical documentation, and research cohort identification, sold via enterprise SaaS to academic cancer centers and health systems.
- Company typePrivate
- Founded2015
- HeadquartersPhiladelphia, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Oncora Medical does
Oncora Medical (rebranded as Oncora AI in July 2025) is a Philadelphia-based digital health company that builds oncology-specific artificial intelligence software for cancer care delivery, cancer registry operations, and oncology clinical research. The company's product suite comprises three core offerings: Registry AI, which automates cancer registry workflows including case finding, NAACCR-compliant data abstraction, and follow-up monitoring; Clinical AI, an oncology-tuned AI scribe and documentation tool that extracts structured oncology data from pathology, radiology, and clinical notes via FHIR interfaces; and Research AI, which automates patient cohort identification, study design, and statistical analysis for oncology clinical trials. Underlying these products is a proprietary domain-specialized LLM trained on data from hundreds of thousands of cancer patients across leading academic cancer centers, integrated with major EHR and oncology information systems including Epic (via FHIR), MOSAIQ, and ARIA.
Oncora sells primarily through a direct enterprise sales motion targeting large academic cancer centers, integrated delivery networks, and hospital cancer registry programs; named customers include MD Anderson Cancer Center, the Mass General-led Pediatric Proton/Photon Consortium Registry (covering 19 radiation centers), Northwell Health, Scripps Health, and UT Health San Antonio. Revenue is generated via SaaS subscription licensing, with a free pathology report analyzer available to drive enterprise pipeline. A strategic channel partnership with Varian (also a $3M investor in 2019) provides distribution leverage into the radiation oncology installed base. The company was founded in 2015 by Dr. David Lindsay and Chris Ahern, has raised roughly $7M+ in disclosed funding across seed and corporate rounds, and in 2025 expanded leadership with CTO Kevin Yee (ex-Microsoft, Genentech) to support its repositioning as an AI-led clinical data abstraction company.
Oncora Medical firmographics
Firmographics- Name
- Oncora Medical
- Legal name
- Oncora Medical, Inc.
- Website
- https://oncora.ai
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Oncora Medical (rebranded as Oncora AI in 2025) is a Philadelphia-based digital health company building oncology-specific AI software for cancer registry automation, clinical documentation, and research cohort identification, sold via enterprise SaaS to academic cancer centers and health systems.
- Ownership category
- akta.pro rank
Oncora Medical industry classification
Industry- Product category
- Oncology AI Software
- NAICS
- Software Publishers (513210), Software Publishers (5132), Custom Computer Programming Services (541511)
- SIC
- Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370), Services-Computer Processing & Data Preparation (7374)
- akta.pro primary industry
- Oncology Pathways & Precision Medicine Decision Support (HLACAGAH)
- akta.pro secondary industries
- Healthcare Terminology, Ontology & Code Set Management (SNOMED/LOINC/ICD/RxNorm) (HLACAIAF), Clinical Decision Support & Workflow Integration (EHR/oncology systems) (HLAAANAE), Biostatistics, Statistical Computing & Clinical Programming (SAS/R/Pipelines) (HLACAOAO)
Keywords
Where Oncora Medical is headquartered
LocationHeadquarters
- HQ city
- Philadelphia
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Oncora Medical business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- Enterprise Software Licensing: SaaS-based software platform subscription model providing access to Registry AI, Clinical AI, and Research AI products with enterprise-level features and support.
- Free Demo Tool: Free demonstration tool for pathology report analysis demonstrating platform capabilities to drive enterprise sales conversions.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Pay-as-you-go | Free demonstration tool for pathology report analysis |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels4 records
Oncora Medical product offering
Product offeringCore offering
Oncora Medical develops AI-powered oncology software products that automate cancer registry workflows, clinical documentation, and clinical research for healthcare organizations. The platform comprises Registry AI (cancer registry automation with NAACCR coding), Clinical AI (oncology-specific AI scribe), and Research AI (clinical research cohort matching and EDC generation), all built on proprietary large language models and integrated with leading EHR systems (Epic, MOSAIQ, ARIA) via FHIR interfaces.
Product overview
Oncora Medical (reincorporated as Oncora AI in 2025) offers a unified oncology AI platform with three core products: Registry AI for cancer registry automation, Clinical AI for AI-powered documentation and scribing, and Research AI for clinical research acceleration. The platform uses FHIR integration to connect with major EHR systems (Epic, MOSAIQ, ARIA) and applies specialized LLM and ML models for data extraction, predictive analytics, and automated coding. All products share a common data infrastructure with NAACCR compliance and are designed to work both independently and as an integrated suite, with a free demonstration tool available for evaluation.
Differentiator
Problem solved
Functional benefit
Brands
- Registry AI: AI-powered cancer registry automation tool that transforms cancer registry workflows, featuring automated case finding, intelligent abstraction to NAACCR format, and real-time follow-up monitoring.
- Clinical AI
- Research AI
- Oncora Patient Care
- Oncora Analytics
Products and services
- Registry AI AI-powered cancer registry automation tool that transforms cancer registries into strategic assets by automatically extracting data from pathology reports, radiology studies, and clinical documents and translating them into standardized NAACCR coding format with quality control, analytics, and insights. Includes intelligent case finding, AI-enabled abstraction, follow-up monitoring, and analytics and reporting modules.
- Clinical AI AI scribe for oncology that extracts critical oncology-specific data from medical documents through FHIR interfaces, creates intuitive cancer care workflows, and generates customized clinical documentation including orders, prescriptions, progress visit notes, and treatment summaries that meet all clinical requirements.
- Research AI Clinical research AI assistant that transforms clinical data into research-ready cohorts by automatically extracting structured data from FHIR sources including pathology reports, radiology studies, and clinical notes. Provides cohort matching, statistical analysis (including Kaplan-Meier survival curves), custom dashboards, collaboration tools, and next-generation EDC form generation.
- Free Medical Document Analyzer Free web-based demonstration tool that transforms pathology reports, radiology reports, and clinical notes into standardized NAACCR coding format using Oncora's AI. Processes sample patient reports client-side without storing PHI to showcase platform capabilities to prospective enterprise customers.
Quantifiable outcome
- Reduces manual case finding review time by up to 85%
- +3 more outcomes
Companies that use Oncora Medical
Customer profileNamed customers6 records
Segments3 records
Ideal customer profiles3 records
Oncora Medical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration6 records
AI capability8 records
Feature7 records
Oncora Medical partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- Mass General Cancer Center (Pediatric Proton/Photon Consortium Registry)coreOncora selected to power the PPCR registry with Oncora Analytics software platform. The registry is a consented registry for pediatric cancer patients enabling rapid research into proton therapy impact on children. Dr. Torunn Yock leads the project. Includes 19 radiation centers including MD Anderson, UPenn, Northwestern, Washington University, and University of Florida.
- TmunitycoreStrategic collaboration to access Oncora's proprietary real-world data platform to support design of future clinical programs with cell therapy. Partnership aims to accelerate availability of CAR-T therapies for cancer patients by leveraging real-world data.
- Northwell HealthcoreNew York's largest health system partnered with Oncora to use data-powered software for targeted cancer treatment. Oncora's software used by Northwell oncologists to develop personalized treatment plans for cancer patients.
- VariancoreVarian invested in Oncora Medical and partnered to accelerate development of software tools for precision medicine in radiation oncology. Partnership combines Varian's radiation oncology systems with Oncora's predictive modeling engine and analytics platform to help doctors design treatments that minimize toxicity risk and maximize chance for cure. Oncora's software was in use at 13 sites at the time of partnership.
- Texas Medical Center (TMCx Accelerator)minorOncora Medical was selected for the 16-week TMCx program at the Texas Medical Center Innovation Institute, described as the largest medical complex in the world, for acceleration and validation support.
- MD Anderson Cancer CentercorePrecision medicine alliance combining tools for collection and prediction of oncology outcomes to enable precision radiation oncology. Oncora Patient Care developed in conjunction with MD Anderson oncologists. Oncora Analytics in use at MD Anderson for research purposes.
Scale indicators6 records
Recent moves7 records
Expansion highlights6 records
Oncora Medical competitors and assessment
Company assessmentMarket position
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Oncora Medical social profiles
Digital presenceOncora Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Oncora Medical leadership team
Management profileNumber of profiles
Profiles5 records
Oncora Medical funding detail
Funding detailFunding overview
Funding rounds5 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Oncora Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Oncora Medical
What does Oncora Medical do?
Oncora Medical develops AI-powered oncology software products that automate cancer registry workflows, clinical documentation, and clinical research for healthcare organizations. The platform comprises Registry AI (cancer registry automation with NAACCR coding), Clinical AI (oncology-specific AI scribe), and Research AI (clinical research cohort matching and EDC generation), all built on proprietary large language models and integrated with leading EHR systems (Epic, MOSAIQ, ARIA) via FHIR interfaces.
Is Oncora Medical a public or private company?
Oncora Medical is a private company. It is classified as venture growth investor backed and is currently operating.
When was Oncora Medical founded?
Oncora Medical was founded in 2015. It employs 11 to 50 people.
Where is Oncora Medical based?
Oncora Medical is headquartered in Philadelphia, United States, in the North America region.
How does Oncora Medical make money?
Two revenue lines are on record. Enterprise Software Licensing is the primary driver. The others are free Demo Tool.
Does Oncora Medical have an API?
No public API is recorded for Oncora Medical.
What industry is Oncora Medical in?
Oncora Medical's product category is Oncology AI Software. Its primary akta.pro industry code is HLACAGAH, Oncology Pathways & Precision Medicine Decision Support, with a secondary code of HLACAIAF, Healthcare Terminology, Ontology & Code Set Management (SNOMED/LOINC/ICD/RxNorm). Its NAICS code is 513210 and its SIC code is 7372.